Regulation of androgen receptor activity by tyrosine phosphorylation.

Cited by (364)

Items 101–200 of 364

1. Therapy escape mechanisms in the malignant prostate
   Frederic Romain Santer, Holger H.H. Erb, Rhiannon Victoria McNeill · 2015 · Seminars in Cancer Biology
2. An Interdomain Interaction of the Androgen Receptor Is Required for Its Aggregation and Toxicity in Spinal and Bulbar Muscular Atrophy
   Christopher R. Orr, Heather L. Montie, Yuhong Liu, Elena Bolzoni, Shannon C. Jenkins, Elizabeth M. Wilson, James D. Joseph, Donald Patrick McDonnell, Diane E. Merry · 2010 · Journal of Biological Chemistry
3. Differential Regulation of Androgen Receptor by PIM-1 Kinases via Phosphorylation-dependent Recruitment of Distinct Ubiquitin E3 Ligases
   Douglas E. Linn, Xi Yang, Yingqiu Xie, Alan Alfano, Dhanraj Deshmukh, Xin Wang, Hermela Shimelis, Hegang Chen, Wěi Li, Kexin Xu et al. · 2012 · Journal of Biological Chemistry
4. 3,3′-Diindolylmethane Enhances Taxotere-Induced Apoptosis in Hormone-Refractory Prostate Cancer Cells through Survivin Down-regulation
   KM Wahidur Rahman, Sanjeev Banerjee, Shadan S. Ali, Aamir Ahmad, Zhiwei Peter Wang, Dejuan Kong, Wael Sakr · 2009 · Cancer Research
5. AR-V7 and prostate cancer: The watershed for treatment selection?
   Chiara Ciccarese, Matteo Santoni, Matteo Brunelli, Sebastiano Buti, Alessandra Modena, Massimo Nabissi, Walter Artibani, Guido Martignoni, Rodolfo Montironi, Giampaolo Tortora et al. · 2015 · Cancer Treatment Reviews
6. Epidermal growth factor induces bladder cancer cell proliferation through activation of the androgen receptor
   Koji Izumi, Yichun Zheng, YI LI, Jacqueline Zaengle, Hiroshi Miyamoto · 2012 · International Journal of Oncology
7. A New Trick of an Old Molecule: Androgen Receptor Splice Variants Taking the Stage?!
   Zhiyong Guo, Yun Qiu · 2011 · International Journal of Biological Sciences
8. Mechanisms of Prostate Cancer Initiation and Progression
   Beatrice S. Knudsen, Valeri I. Vasioukhin · 2010 · Advances in cancer research
9. MAPK4 promotes prostate cancer by concerted activation of androgen receptor and AKT
   Tao Shen, Wei Wang, Wolong Zhou, Ilsa M. Coleman, Qinbo Cai, Bingning Dong, Michael Ittmann, Chad J. Creighton, Yingnan Bian, Yan–Ling Meng et al. · 2021 · Journal of Clinical Investigation
10. SIRNA-Directed In Vivo Silencing of Androgen Receptor Inhibits the Growth of Castration-Resistant Prostate Carcinomas
    Daniel Compagno, Carole Arnold, Aurélie Morin, Cristèle Gilbert, Jacques R.R. Mathieu, Aline Bözec, Claire Mauduit, Mohamed Benahmed, Florence Cabon · 2007 · PLoS ONE
11. p66Shc as a switch in bringing about contrasting responses in cell growth: implications on cell proliferation and apoptosis
    Sahar S Bhat, Deepak Anand, Firdous Ahmad Khanday · 2015 · Molecular Cancer
12. Increased expression and differential phosphorylation of stathmin may promote prostate cancer progression
    Ritwik Ghosh, Guangyu Gu, Erin Tillman, Jialing Yuan, Yongqing Wang, Ladan Fazli, Paul S. Rennie, Susan Kasper · 2007 · The Prostate
13. Outsmarting androgen receptor: creative approaches for targeting aberrant androgen signaling in advanced prostate cancer
    Karen E. Knudsen, William Kevin Kelly · 2011 · Expert Review of Endocrinology & Metabolism
14. The Neuroendocrine-Derived Peptide Parathyroid Hormone–Related Protein Promotes Prostate Cancer Cell Growth by Stabilizing the Androgen Receptor
    John O. DaSilva, Daniel G. Gioeli, Michael J. Weber, Sarah J. Parsons · 2009 · Cancer Research
15. The expression of AURKA is androgen regulated in castration-resistant prostate cancer
    Kati K. Kivinummi, Alfonso Urbanucci, Katri A. Leinonen, Teuvo L.J. Tammela, Matti Annala, William B. Isaacs, G. Steven Bova, Matti Nykter, Tapio Visakorpi · 2017 · Scientific Reports
16. Long-Chain Acyl-CoA Synthetase 4–Mediated Fatty Acid Metabolism Sustains Androgen Receptor Pathway–Independent Prostate Cancer
    Yongjie Ma, Xiaohan Zhang, Omar Awad Alsaidan, Xiangkun Yang, Essilvo Sulejmani, Junyi Zha, Zanna M. Beharry, Hanwen Huang, Michael G. Bartlett, Zachary Lewis et al. · 2020 · Molecular Cancer Research
17. Effect of the Specific Src Family Kinase Inhibitor Saracatinib on Osteolytic Lesions Using the PC-3 Bone Model
    Joy C. Yang, Lanfang Bai, Stanley A. Yap, Allen C. Gao, Hsing-Jien Kung, Christopher P. Evans · 2010 · Molecular Cancer Therapeutics
18. Discovery of BMS-641988, a Novel and Potent Inhibitor of Androgen Receptor Signaling for the Treatment of Prostate Cancer
    Ricardo M. Attar, Maria Jure‐Kunkel, Aaron Balog, Mary Ellen Cvijic, Janet Dell-John, Cheryl A. Rizzo, Liang Schweizer, Thomas E. Spires, J. Suso Platero, Mary T. Obermeier et al. · 2009 · Cancer Research
19. Choline Kinase Alpha as an Androgen Receptor Chaperone and Prostate Cancer Therapeutic Target
    Mohammad Asim, Charles E. Massie, Folake A. Orafidiya, Nelma Pértega‐Gomes, Anne Yvonne Warren, Mohsen Esmaeili, Luke A. Selth, Heather Ireland Zecchini, Katarina Luko, Arham Qureshi et al. · 2015 · JNCI Journal of the National Cancer Institute
20. The Molecular Evolution of Castration-resistant Prostate Cancer
    Yvonne Ceder, Anders S Bjartell, Zoran Čulig, Mark A. Rubin, Scott A. Tomlins, Tapio Visakorpi · 2016 · European Urology Focus
21. Myristoylation of Src kinase mediates Src-induced and high-fat diet–accelerated prostate tumor progression in mice
    Sung‐Jin Kim, Xiangkun Yang, Qianjin Li, Meng Wu, Leah J. Costyn, Zanna M. Beharry, Michael G. Bartlett, Houjian Cai · 2017 · Journal of Biological Chemistry
22. TACC2 Is an Androgen-Responsive Cell Cycle Regulator Promoting Androgen-Mediated and Castration-Resistant Growth of Prostate Cancer
    Ken‐ichi Takayama, Kuniko Horie‐Inoue, Takashi A. SUZUKI, Tomohiko Urano, Kazuhiro Ikeda, Tetsuya Fujimura, Satoru Takahashi, Yukio Homma, Yasuyoshi Ouchi, Satoshi Inoue · 2012 · Molecular Endocrinology
23. Functional screen identifies kinases driving prostate cancer visceral and bone metastasis
    Claire M. Faltermeier, Justin M. Drake, Peter M. Clark, Bryan A. Smith, Yang Zong, Carmen Volpe, Colleen Mathis, Colm M. Morrissey, Brandon Castor, Jiaoti Huang et al. · 2015 · Proceedings of the National Academy of Sciences
24. The importance of non-nuclear AR signaling in prostate cancer progression and therapeutic resistance
    Jelani C. Zarif, Cindy K. Miranti · 2016 · Cellular Signalling
25. Autophagy in Prostate Cancer and Androgen Suppression Therapy
    Elio Ziparo A, Simonetta Petrungaro, Elettra Sara Marini, Donatella Starace, Silvia Conti, Antonio Facchiano, Antonio Filippini, Claudia Giampietri · 2013 · International Journal of Molecular Sciences
26. Oncogenic activation of androgen receptor
    Hsing-Jien Kung, Christopher P. Evans · 2008 · Urologic Oncology Seminars and Original Investigations
27. Androgen Receptor Expression in Prostate Cancer Cells Is Suppressed by Activation of Epidermal Growth Factor Receptor and ErbB2
    Changmeng Cai, David Craig Portnoy, Hongyun Wang, Xinnong Jiang, Shaoyong Chen, Steven P. Balk · 2009 · Cancer Research
28. Targeted therapy of cancer: new roles for pathologists—prostate cancer
    Mark A. Rubin · 2008 · Modern Pathology
29. The testosterone paradox of advanced prostate cancer: mechanistic insights and clinical implications
    Rajendra Kumar, Laura A. Sena, Samuel Ray Denmeade, Sushant K. Kachhap · 2022 · Nature Reviews Urology
30. International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily—Update 2023
    Thomas P. Burris, Ian Mitchelle S. de Vera, Isabelle Côté, Colin A. Flaveny, Udayanga S. Wanninayake, Arindam Chatterjee, John K. Walker, Nickolas Steinauer, Jinsong Zhang, Laurel A. Coons et al. · 2023 · Pharmacological Reviews
31. Metformin Inhibits Androgen-Induced IGF-IR Up-Regulation in Prostate Cancer Cells by Disrupting Membrane-Initiated Androgen Signaling
    Roberta Malaguarnera, Antonella Sacco, Alaide Morcavallo, Sebastiano Squatrito, Antimo Migliaccio, Andrea Morrione, Marcello Maggiolini, Antonino Belfiore · 2014 · Endocrinology
32. Targeting Tyrosine Kinases and Autophagy in Prostate Cancer
    Hsing-Jien Kung · 2010 · Hormones and Cancer
33. Loss of Androgen-Regulated MicroRNA 1 Activates SRC and Promotes Prostate Cancer Bone Metastasis
    Yen‐Nien Liu, JuanJuan Yin, Ben Barrett, Heather Sheppard, Dongmei Li, Orla M. Casey, Lei Fang, Paul G. Hynes, Amir H. Ameri, Kathleen Kelly · 2015 · Molecular and Cellular Biology
34. Molecular processes leading to aberrant androgen receptor signaling and castration resistance in prostate cancer
    Rong Hu, Samuel Ray Denmeade, Jun Luo · 2010 · Expert Review of Endocrinology & Metabolism
35. Phosphoproteomics for the discovery of kinases as cancer biomarkers and drug targets
    Li‐Rong Yu, Haleem J. Issaq, Timothy D. Veenstra · 2007 · PROTEOMICS - CLINICAL APPLICATIONS
36. p66Shc—a longevity redox protein in human prostate cancer progression and metastasis
    Mythilypriya Rajendran, Paul G. Thomes, Li Zhang, Suresh Veeramani, Ming‐Fong Lin · 2010 · Cancer and Metastasis Reviews
37. Non-genomic signaling of steroid receptors in cancer
    C. Thiébaut, Virginie Vlaeminck‐Guillem, Olivier Trédan, Coralie Poulard, Muriel Le Romancer · 2021 · Molecular and Cellular Endocrinology
38. PIAS1 is a determinant of poor survival and acts as a positive feedback regulator of AR signaling through enhanced AR stabilization in prostate cancer
    Martin Puhr, Julia Hoefer, Andrea Eigentler, Dimo Dietrich, Geert van Leenders, Barbara Uhl, Marije Hoogland, Florian Handle, Bettina Schlick, Hannes Neuwirt et al. · 2015 · Oncogene
39. Experimental Evidence of Persistent Androgen-Receptor-Dependency in Castration-Resistant Prostate Cancer
    Takashi Kobayashi, Takahiro Inoue, Tomomi Kamba, Osamu Ogawa · 2013 · International Journal of Molecular Sciences
40. Protein conformational switch discerned via network centrality properties
    David Foutch, Bill Pham, Tongye Shen · 2021 · Computational and Structural Biotechnology Journal
41. Src: Marker or Actor in Prostate Cancer Aggressiveness
    Virginie Vlaeminck‐Guillem, Germain Gillet, Ruth Rimokh · 2014 · Frontiers in Oncology
42. Pharmacological Targeting of Constitutively Active Truncated Androgen Receptor by Nigericin and Suppression of Hormone-Refractory Prostate Cancer Cell Growth
    Tetsuo Mashima, Sachiko Okabe, Hiroyuki Seimiya · 2010 · Molecular Pharmacology
43. Activation of Rac1 Is Closely Related to Androgen-Independent Cell Proliferation of Prostate Cancer Cells Both in Vitro and in Vivo
    Takashi Kobayashi, Takahiro Inoue, Yosuke Shimizu, Naoki Terada, Atsushi Maeno, Yoichiro Kajita, Toshinari Yamasaki, Tomomi Kamba, Yoshinobu Toda, Yoshiki Mikami et al. · 2010 · Molecular Endocrinology
44. Estrogen receptor β expression and androgen receptor phosphorylation correlate with a poor clinical outcome in hormone-naïve prostate cancer and are elevated in castration-resistant disease
    Tobias Zellweger, Susanne Stürm, Silvia Rey, Inti Zlobec, Joel R. Gsponer, Cyrill A. Rentsch, Luigi Terracciano, Alexander Bachmann, Lukas Bubendorf, Christian Felipe Ruiz · 2013 · Endocrine Related Cancer
45. The molecular mechanism of Vav3 oncogene on upregulation of androgen receptor activity in prostate cancer cells
    Lu · 2010 · International Journal of Oncology
46. UGT2B17 Expedites Progression of Castration-Resistant Prostate Cancers by Promoting Ligand-Independent AR Signaling
    Haolong Li, Ning Xie, Ruiqi Chen, Mélanie Verreault, Ladan Fazli, Martin Edwin Gleave, Olivier Barbier, Xuesen Dong · 2016 · Cancer Research
47. Src promotes castration-recurrent prostate cancer through androgen receptor-dependent canonical and non-canonical transcriptional signatures
    Indranil Chattopadhyay, Jianmin Wang, Maochun Qin, Lingqiu Gao, Renae Holtz, Robert L. Vessella, Robert W. Leach, Irwin H. Gelman · 2016 · Oncotarget
48. CLDN 8 , an androgen‐regulated gene, promotes prostate cancer cell proliferation and migration
    Daisaku Ashikari, Ken‐ichi Takayama, Daisuke Obinata, Satoru Takahashi, Satoshi Inoue · 2017 · Cancer Science
49. Androgen Physiology: Receptor and Metabolic Disorders
    Iain J. McEwan, Albert O. Brinkmann · 2016
50. Inhibition of glycogen synthase kinase‐3β promotes nuclear export of the androgen receptor through a CRM1‐dependent mechanism in prostate cancer cell lines
    Stefanie Veronika Schütz, Marcus Victor Cronauer, Ludwig J. Rinnab · 2010 · Journal of Cellular Biochemistry
51. Src kinase inhibitors: an emerging therapeutic treatment option for prostate cancer
    Joanne Edwards · 2010 · Expert Opinion on Investigational Drugs
52. Impact of the SRC inhibitor dasatinib on the metastatic phenotype of human prostate cancer cells
    Lori P. Rice, Sharon E. Lepler, Christina Pampo, Dietmar W. Siemann · 2011 · Clinical & Experimental Metastasis
53. Crosstalk Between Nuclear MET and SOX9/β-Catenin Correlates with Castration-Resistant Prostate Cancer
    Yingqiu Xie, Wenfu Lu, Shenji Liu, Qing Yang, Brett Stewart Carver, Estelle Li, Yuzhuo Z. Wang, Ladan Fazli, Martin Edwin Gleave, Zhenbang Chen · 2014 · Molecular Endocrinology
54. Correlation of AR, EGFR, and HER2 Expression Levels in Prostate Cancer: Immunohistochemical Analysis and Chromogenic In Situ Hybridization
    Kwang Hyun Baek, Min Eui Hong, Yoon Yang Jung, Chung Hun Lee, Tae Jin Lee, Eon Sub Park, Mi Kyung Kim, Jae Hyung Yoo, Soo Whan Lee · 2012 · Cancer Research and Treatment
55. PSA regulates androgen receptor expression in prostate cancer cells
    Parmita Saxena, Marco Trerotola, Tao Wang, Jing Li, Aejaz Sayeed, Jennifer VanOudenhove, Dave S. Adams, Thomas J. FitzGerald, Dario C. Altieri, Lucia Raffaella Languino · 2011 · The Prostate
56. Amino acid containing thapsigargin analogues deplete androgen receptor protein via synthesis inhibition and induce the death of prostate cancer cells
    Donald J. Vander Griend, Lizamma Antony, Susan L. Dalrymple, Yi Xu, S. Brøgger Christensen, Samuel Ray Denmeade, John T. Isaacs · 2009 · Molecular Cancer Therapeutics
57. Acetylation of androgen receptor by ARD1 promotes dissociation from HSP90 complex and prostate tumorigenesis
    John S. DePaolo, Zehua Wang, Jianhui Guo, Guanyi Zhang, Chiping Qian, Haitao Zhang, Jovanny Zabaleta, Wanguo Liu · 2016 · Oncotarget
58. A role for the androgen-receptor in clinically localized and advanced prostate cancer
    James Lloyd Mohler · 2008 · Best Practice & Research Clinical Endocrinology & Metabolism
59. Androgen receptor molecular biology and potential targets in prostate cancer
    Elizabeth M. Wilson · 2010 · Therapeutic Advances in Urology
60. Ligand-dependent Corepressor Acts as a Novel Androgen Receptor Corepressor, Inhibits Prostate Cancer Growth, and Is Functionally Inactivated by the Src Protein Kinase
    Mohammad Asim, Bilal Bin Hafeez, Imtiaz Ahmad Siddiqui, Claudia Gerlach, Michaela Patz, Hasan Mukhtar, Aria Baniahmad · 2011 · Journal of Biological Chemistry
61. PARK7/DJ-1 dysregulation by oxidative stress leads to magnesium deficiency: implications in degenerative and chronic diseases
    Martin Kolísek, Augusto C. I. Montezano, Gerhard Sponder, Aikaterini Anagnostopoulou, Jürgen Vormann, Rhian M. Touyz, Jörg Rudolf Aschenbach · 2015 · Clinical Science
62. MST1 Is a Multifunctional Caspase-Independent Inhibitor of Androgenic Signaling
    Bekir Cinar, Filiz Kisaayak Collak, Delia Lopez, Seçkin Akgül, Nishit K. Mukhopadhyay, Murat Kilicarslan, Daniel G. Gioeli, Michael R. Freeman · 2011 · Cancer Research
63. A novel role of Shc adaptor proteins in steroid hormone-regulated cancers
    Syed Mahfuzul Alam, Mythilypriya Rajendran, Shouqiang Ouyang, Suresh Veeramani, Li Zhang, Ming-Fong Lin · 2008 · Endocrine Related Cancer
64. Phosphorylation and activation of androgen receptor by Aurora-A.
    Shu, Shao-Kun, Liu, Qiyuan, Coppola, Domenico, Cheng, Jin Q. · 2010 · Journal of Biological Chemistry · Retracted
65. Steroid Receptors in Breast Cancer: Understanding of Molecular Function as a Basis for Effective Therapy Development
    Wojciech Kowalczyk, Grzegorz Waliszczak, Robert Jach, Joanna Dulińska-Litewka · 2021 · Cancers
66. Regulation of androgen receptor transactivity and mTOR–S6 kinase pathway by Rheb in prostate cancer cell proliferation
    Takashi Kobayashi, Yosuke Shimizu, Naoki Terada, Toshinari Yamasaki, Eijiro Nakamura, Yoshinobu Toda, Hiroyuki Nishiyama, Toshiyuki Kamoto, Osamu Ogawa, Takahiro Inoue · 2010 · The Prostate
67. Increased PrLZ-mediated androgen receptor transactivation promotes prostate cancer growth at castration-resistant stage
    Lei Li, Hongjun Xie, Liang Liang, Ye Gao, Dong Zhang, Lei‐Ya Fang, Soo Ok Lee, Jie Luo, Xingfa Chen, Xinyang Wang et al. · 2012 · Carcinogenesis
68. Treatment options in castration-resistant prostate cancer: Current therapies and emerging docetaxel-based regimens
    Fred Saad C, Kurt Miller · 2013 · Urologic Oncology Seminars and Original Investigations
69. YES1 Activation Elicited by Heat Stress Is Anti-Apoptotic in Mouse Pachytene Spermatocytes1
    Yuan Liang, Yushu Dong, Jie Zhao, Wei Li · 2013 · Biology of Reproduction
70. TPL2/COT/MAP3K8 (TPL2) Activation Promotes Androgen Depletion-Independent (ADI) Prostate Cancer Growth
    Joseph H. Jeong, Ayesha Bhatia, Zsolt Toth, Soohwan Oh, Kyung‐Soo Inn, Chun‐Peng Liao, Pradip Roy‐Burman, Jonathan Melamed, Gerhard A. Coetzee, Jae Ung Jung · 2011 · PLoS ONE
71. The metastasis suppressor NDRG1 directly regulates androgen receptor signaling in prostate cancer
    Syer Choon Lim, Bekesho Geleta, Sanaz Maleki, Des Raymond Richardson, Žaklina Kovačević · 2021 · Journal of Biological Chemistry
72. Drug resistance in metastatic castration-resistant prostate cancer: an update on the status quo
    Amani Yehya, Fatima Ghamlouche, Amin Zahwe, Yousef Zeid, Kevork Wakimian, Deborah Mukherji, Wassim G. Abou-Kheir · 2022 · Cancer Drug Resistance
73. Androgen Receptor Activation in Castration-Recurrent Prostate Cancer: The Role of Src-Family and Ack1 Tyrosine Kinases
    Irwin H. Gelman · 2014 · International Journal of Biological Sciences
74. A Naturally Derived Small Molecule Disrupts Ligand-Dependent and Ligand-Independent Androgen Receptor Signaling in Human Prostate Cancer Cells
    Karishma S. Amin, Shankar Jagadeesh, Gakul Baishya, Paruchuri Gangadhar Rao, Nabin Chandra Barua, Samir Bhattacharya, Partha P. Banerjee · 2013 · Molecular Cancer Therapeutics
75. Soluble factors derived from stroma activated androgen receptor phosphorylation in human prostate LNCaP cells: Roles of ERK/MAP kinase
    Katsumi Shigemura, Shuji Isotani, Ruoxiang Wang, Masato Fujisawa, Akinobu Gotoh, Fray F. Marshall, Haiyen E. Zhau, Leland W.K. Chung · 2009 · The Prostate
76. Human constitutive androstane receptor represses liver cancer development and hepatoma cell proliferation by inhibiting erythropoietin signaling
    Zhihui Li, So Mee Kwon, Daochuan Li, Linhao Li, Xiwei Peng, Junran Zhang, Tatsuya Sueyoshi, Jean‐Pierre Raufman, Masahiko Negishi, Xin Wei Wang et al. · 2022 · Journal of Biological Chemistry
77. Blockade of ACK1/TNK2 To Squelch the Survival of Prostate Cancer Stem-like Cells
    Nupam P. Mahajan, Domenico Coppola, Jongphil Kim, Harshani R. Lawrence, Nicholas J. Lawrence, Kiran N. Mahajan · 2018 · Scientific Reports
78. MTA family of proteins in prostate cancer: biology, significance, and therapeutic opportunities
    Anait S. Levenson, Avinash Kumar, Xu Zhang · 2014 · Cancer and Metastasis Reviews
79. Combined transcriptome and metabolome analyses of metformin effects reveal novel links between metabolic networks in steroidogenic systems
    Sameer S. Udhane, Balázs Legeza, Nesa Marti, Damian Hertig, Gaëlle Diserens, Jean‐Marc Nuoffer, Peter Vermathen, Christa E. Flück · 2017 · Scientific Reports
80. Biology of Castration-Recurrent Prostate Cancer
    Faris S. Azzouni, James Lloyd Mohler · 2012 · Urologic Clinics of North America
81. Endothelin‐1 enhances the expression of the androgen receptor via activation of the c‐myc pathway in prostate cancer cells
    June G. Lee, Rong Zheng, Jennifer M. McCafferty‐Cepero, Kerry L. Burnstein, David M. Nanus, Ruoqian Shen · 2008 · Molecular Carcinogenesis
82. The biology of castration-resistant prostate cancer
    Fei Lian, Nitya V. Sharma, Josue D. Moran, Carlos S. Moreno · 2014 · Current Problems in Cancer
83. Lyn tyrosine kinase regulates androgen receptor expression and activity in castrate-resistant prostate cancer
    Anousheh Zardan, Ka Mun Nip, Daksh Thaper, Paul Toren, Sepideh Vahid, Eliana Beraldi, Ladan Fazli, François Lamoureux, Kilian Martin Gust, Michael Cox et al. · 2014 · Oncogenesis
84. Differential Requirement for Src Family Tyrosine Kinases in the Initiation, Progression, and Metastasis of Prostate Cancer
    Irwin H. Gelman, Jennifer Peresie, Kevin Hasegawa Eng, Barbara A. Foster · 2014 · Molecular Cancer Research
85. The role of protein tyrosine phosphatases in prostate cancer biology
    Caroline E. Nunes‐Xavier, Janire Mingo, Jose Ignacio Lopez, Rafael Pulido · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
86. Nuclear MET requires ARF and is inhibited by carbon nanodots through binding to phospho-tyrosine in prostate cancer
    Yingqiu Xie, Haiyan Fan, Wenfu Lu, Qing Yang, Ayan Nurkesh, Tleubek Yeleusizov, Aisulu Maipas, Lu Jiang, Limara Manarbek, Zhenbang Chen et al. · 2018 · Oncogene
87. Activation of the DNA-dependent Protein Kinase Stimulates Nuclear Export of the Androgen Receptor in Vitro
    Leonard C. Shank, Joshua B. Kelley, Daniel G. Gioeli, Chunsong Yang, Adam Spencer, Lizabeth A. Allison, Bryce M. Paschal · 2008 · Journal of Biological Chemistry
88. Src-family tyrosine kinases as therapeutic targets in advanced cancer
    Gelman, Irwin H · 2011 · Frontiers in Bioscience
89. LMO2 upregulation due to AR deactivation in cancer-associated fibroblasts induces non-cell-autonomous growth of prostate cancer after androgen deprivation
    Lei Chen, Yue-Yang Wang, Li Deng, Cheng Wang, Shi-Yuan Wang, Sihui Shao, Zhengyang Zhu, Jing Zhao, Yu Zhang, Yuan Ruan et al. · 2021 · Cancer Letters
90. CDC25A Functions as a Novel Ar Corepressor in Prostate Cancer Cells
    Yung‐Tuen Chiu, Huiying Han, Steve C.L. Leung, Hiu‐Fung Yuen, Chee-Wai Chau, Zhiyong Guo, Yun Qiu, Kwok‐Wah Chan, Xianghong Wang, Yong-Chuan Wong et al. · 2008 · Journal of Molecular Biology
91. Extracellular Signal-Regulated Kinase Positively Regulates the Oncogenic Activity of MCT-1 in Diffuse Large B-Cell Lymphoma
    Bojie Dai, X. Frank Zhao, Patrick Ryan Hagner, Paul Shapiro, Krystyna Mazan-Mamczarz, Shuchun Zhao, Yasodha Natkunam, Ronald B. Gartenhaus · 2009 · Cancer Research
92. Androgen receptor abnormalities in castration-recurrent prostate cancer.
    Nacusi, Lucas P, Tindall, Donald J · 2009 · Expert Review of Endocrinology & Metabolism
93. Intracellular Signaling Pathways Regulate Hormone-Dependent Kallikrein Gene Expression
    Miltiadis Paliouras, Eleftherios P. Diamandis · 2008 · Tumor Biology
94. The Fer tyrosine kinase acts as a downstream interleukin-6 effector of androgen receptor activation in prostate cancer
    Joice Rocha, Fatima Z. Zouanat, Amina Zoubeidi, L. Hamel, Tarik Benidir, Eleonora Scarlata, Fadi Brimo, Armen Garo Aprikian, Simone Chevalier · 2013 · Molecular and Cellular Endocrinology
95. DUSP22 suppresses prostate cancer proliferation by targeting the EGFR‐AR axis
    Hsiu-Ping Pearl Lin, Hui‐Min Ho, Cheng‐Wei Chang, Shauh‐Der Yeh, Yu‐Wen Su, Tse‐Hua Tan, Wen‐Jye Lin · 2019 · The FASEB Journal
96. Androgen receptor signaling in non-prostatic malignancies: challenges and opportunities
    G. Dotto, An Buckinx, B. Özdemir, Christian Simon · 2024 · Nature Reviews. Cancer
97. PIM1 kinase as a promise of targeted therapy in prostate cancer stem cells
    Yingqiu Xie, Samat Bayakhmetov · 2015 · Molecular and Clinical Oncology
98. Interaction of the phosphorylated DNA-binding domain in nuclear receptor CAR with its ligand-binding domain regulates CAR activation
    Ryota Shizu, Jungki Min, Mack Sobhany, Lars Christian Pedersen, Shingo Mutoh, Masahiko Negishi · 2017 · Journal of Biological Chemistry
99. High‐Content Screening Identifies Src Family Kinases as Potential Regulators of AR‐V7 Expression and Androgen‐Independent Cell Growth
    Adam T. Szafran, Cliff Stephan, Michael J. Bolt, Maureen G. Mancini, Marco Marcelli, Michael A. Mancini · 2016 · The Prostate
100. Caffeic acid phenethyl ester suppresses androgen receptor signaling and stability via inhibition of phosphorylation on Ser81 and Ser213
     Ying‐Yu Kuo, Chieh Huo, Ching‐Yu Lin, Hui‐Ping Lin, Jai-Shin Liu, Wen‐Ching Wang, Chuang‐Rung Chang, Chih‐Pin Chuu · 2019 · Cell Communication and Signaling